Hypermethylation of TMEM240 predicts poor hormone therapy response and disease progression in breast cancer

• 主要な著者: Ruo-Kai Lin (著者), Chih-Ming Su (著者), Shih-Yun Lin (著者), Le Thi Anh Thu (著者), Phui-Ly Liew (著者), Jian-Yu Chen (著者), Huey-En Tzeng (著者), Yun-Ru Liu (著者), Tzu-Hao Chang (著者), Cheng-Yang Lee (著者), Chin-Sheng Hung (著者)
• フォーマット: 図書
• 出版事項: BMC, 2022-06-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Abstract Background Approximately 25% of patients with early-stage breast cancer experience cancer progression throughout the disease course. Alterations in TMEM240 in breast cancer were identified and investigated to monitor treatment response and disease progression. Methods Circulating methylated...